Novartis Can't Block Generics Ahead Of MS Patent Grant
A judge has refused to hand pharma giant Novartis an injunction stopping several generic-drug makers from entering the market for a multiple sclerosis drug that it is soon to be granted...To view the full article, register now.
Already a subscriber? Click here to view full article